First Morning Pregnanetriol and 17-Hydroxyprogesterone Correlated Significantly in 21-Hydroxylase Deficiency.

Itonaga, Tomoyo; Izawa, Masako; Hamajima, Takashi; Hasegawa, Yukihiro

Itonaga, Tomoyo; Izawa, Masako; Hamajima, Takashi; Hasegawa, Yukihiro.

Afiliação

Itonaga T; Division of Endocrinology and Metabolism, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan.
Izawa M; Department of Pediatrics, Oita University Faculty of Medicine, Oita, Japan.
Hamajima T; Department of Pediatric Endocrinology and Metabolism, Aichi Children's Health and Medical Center, Aichi, Japan.
Hasegawa Y; Department of Pediatric Endocrinology and Metabolism, Aichi Children's Health and Medical Center, Aichi, Japan.

Front Endocrinol (Lausanne) ; 12: 808254, 2021.

Article em En | MEDLINE | ID: mdl-35140686

Assuntos

Hiperplasia Suprarrenal Congênita; Pregnanotriol; 17-alfa-Hidroxiprogesterona/uso terapêutico; Adolescente; Hiperplasia Suprarrenal Congênita/tratamento farmacológico; Adulto; Criança; Pré-Escolar; Humanos; Pregnanotriol/uso terapêutico; Pregnanotriol/urina; Estudos Prospectivos; Adulto Jovem

Palavras-chave

17-hydroxyprogesterone; 21-hydroxylase deficiency; Urinary pregnanetiol; congenital adrenal hyperplasia; first morning urine sample; therapy monitoring, glucocorticoid

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pregnanotriol / Hiperplasia Suprarrenal Congênita Tipo de estudo: Observational_studies Limite: Adolescent / Adult / Child / Child, preschool / Humans Idioma: En Revista: Front Endocrinol (Lausanne) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Japão

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google